on The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Position in Spire Healthcare Group
On May 8, 2026, The Vanguard Group, Inc. released a Form 8.3, disclosing its position in Spire Healthcare Group plc. This disclosure is in accordance with Rule 8.3 of the Takeover Code. Vanguard holds 14,451,816 ordinary shares in Spire, representing a 3.59% interest. This marks a significant stake in the healthcare company.
The disclosure reveals a sale of 69,263 ordinary shares at 1.58 GBP each, with no cash-settled derivative positions reported. No agreements or arrangements relating to options or derivatives are noted, indicating a straightforward equity position without additional complexities.
The Vanguard Group did not attach a Supplemental Form 8, suggesting no open derivative positions. The contact for this disclosure is Shawn Acker, available at 001-610-669-6713.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news